FOLLOWUS
1. The First Affiliated Hospital of Shenzhen University,Guangdong Province,Shenzhen,China
2. The Second Clinical Medical College of Jinan University,Guangdong Province,Shenzhen,China
3. Larry Hillblom Islet Research Center, David Geffen School of Medicine, UCLA,Los Angeles,USA
纸质出版日期:2015,
网络出版日期:2014-7-31,
Scan for full text
Li, Yh., Wu, Zz., Cao, Mq. et al. Effect of Tiantai No.1 (天泰1号) on gene expression profiles in hippocampus of Alzheimer’s disease rats by bioinformatic analysis., Chin. J. Integr. Med. 21, 123–131 (2015). https://doi.org/10.1007/s11655-014-1773-3
Ying-hong Li, Zheng-zhi Wu, Mei-qun Cao, et al. Effect of Tiantai No.1 (天泰1号) on gene expression profiles in hippocampus of Alzheimer’s disease rats by bioinformatic analysis[J]. Chinese Journal of Integrative Medicine, 2015,21(2):123-131.
Li, Yh., Wu, Zz., Cao, Mq. et al. Effect of Tiantai No.1 (天泰1号) on gene expression profiles in hippocampus of Alzheimer’s disease rats by bioinformatic analysis., Chin. J. Integr. Med. 21, 123–131 (2015). https://doi.org/10.1007/s11655-014-1773-3 DOI:
Ying-hong Li, Zheng-zhi Wu, Mei-qun Cao, et al. Effect of Tiantai No.1 (天泰1号) on gene expression profiles in hippocampus of Alzheimer’s disease rats by bioinformatic analysis[J]. Chinese Journal of Integrative Medicine, 2015,21(2):123-131. DOI: 10.1007/s11655-014-1773-3.
To study the effect of Tiantai No. 1 (天泰1号) on gene expression profile in hippocampus of Alzheimer’s disease (AD) rat
molecular genetic target points of the effect of this drug were defined
its molecular genetic pharmacodynamic mechanism of anti-AD was further explored at molecular gene level
and a scientific basis was provided for its clinical availability and promotion. Thirty male Sprague-Dawley rats were divided into three groups with 10 rats per group: sham-operation group
model group and Tiantai No. 1 group. Sterile surgical procedure was applied
the model group with bilateral hippocampal injection of Aβ1–40 was established
and normal saline was used instead of Aβ1–40 in the sham-operation group. One week after the models was made
rats were administered by gastric lavage once every day for three consecutive weeks. The rats of the sham-operation group and the model group were daily fed with purified water by lavage; the rats of the Tiantai No.1 group treated group were administered with Tiantai No.1 by lavage. Total RNAs of hippocampus tissues were extracted with Trizol
the changes of hippocampus gene expression profiles in the above three groups were analyzed by using Affymetrix rat whole genome expression profile microarray. Microarray analysis showed that
compared with the sham-operation group
the hippocampus of the model group had 50 up-regulated genes with significant difference (fold change >2)
and 21 down-regulated genes with significant difference (fold change <0.5); compared with the hippocampus of the model group
the hippocampus of the Tiantai No. 1 group was found to have 5 up-regulated genes with significant difference (fold change >2) and 20 down-regulated genes with significant difference (fold change <0.5). The functions of differentially expressed genes of the groups were involved in nervous system’s development
neuronic differentiation and function-regulation
cellular growth and differentiation and apoptosis
synaptic occurrence and plasticity
inflammation and immune response
ion channels/transporters
cellular signal transduction
cellular material/energy metabolism and so on. Tiantai No. 1 can regulate hippocampal function
and further regulate the brain function of animals in multiple gene target points by a number of ways.
To study the effect of Tiantai No. 1 (天泰1号) on gene expression profile in hippocampus of Alzheimer’s disease (AD) rat
molecular genetic target points of the effect of this drug were defined
its molecular genetic pharmacodynamic mechanism of anti-AD was further explored at molecular gene level
and a scientific basis was provided for its clinical availability and promotion. Thirty male Sprague-Dawley rats were divided into three groups with 10 rats per group: sham-operation group
model group and Tiantai No. 1 group. Sterile surgical procedure was applied
the model group with bilateral hippocampal injection of Aβ1–40 was established
and normal saline was used instead of Aβ1–40 in the sham-operation group. One week after the models was made
rats were administered by gastric lavage once every day for three consecutive weeks. The rats of the sham-operation group and the model group were daily fed with purified water by lavage; the rats of the Tiantai No.1 group treated group were administered with Tiantai No.1 by lavage. Total RNAs of hippocampus tissues were extracted with Trizol
the changes of hippocampus gene expression profiles in the above three groups were analyzed by using Affymetrix rat whole genome expression profile microarray. Microarray analysis showed that
compared with the sham-operation group
the hippocampus of the model group had 50 up-regulated genes with significant difference (fold change >2)
and 21 down-regulated genes with significant difference (fold change <0.5); compared with the hippocampus of the model group
the hippocampus of the Tiantai No. 1 group was found to have 5 up-regulated genes with significant difference (fold change >2) and 20 down-regulated genes with significant difference (fold change <0.5). The functions of differentially expressed genes of the groups were involved in nervous system’s development
neuronic differentiation and function-regulation
cellular growth and differentiation and apoptosis
synaptic occurrence and plasticity
inflammation and immune response
ion channels/transporters
cellular signal transduction
cellular material/energy metabolism and so on. Tiantai No. 1 can regulate hippocampal function
and further regulate the brain function of animals in multiple gene target points by a number of ways.
whole genomegenome microarraygene expression profileTiantai No. 1Alzheimer’s diseasehippocampus
whole genomegenome microarraygene expression profileTiantai No. 1Alzheimer’s diseasehippocampus
Meier-Ruge W, Iwangoff P, Bertoni-Freddari C. What is primary and what secondary for amyloid deposition in Alzheimer’s disease? Ann N Y Acad Sci 1994;719:230–237.
Masliah E. Neuropathology: Alzheimer’s in real time. Nature 2008;451:638–639.
Mruthinti S, Capito N, Sood A, Buccafusc JJ. Cytotoxicity of Abeta1-42, RAGE23-54, and an Abeta-RAGE complex in PC-12 cells. Curr Alzheimer Res 2007;4:581–586.
Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Hara H, et al. The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer’s disease. Mini Rev Med Chem 2007;7:1001–1008.
Jain KK. Biochip for gene spotting. Science 2001;294:621–623.
Orlov YL, Zhou J, Lipovich L, Shahab A, Kuznetsov VA. Quality assessment of the Affymetrix U133A & B probesets by target sequence mapping and expression data analysis. In Silico Bio 2007;7:241–260.
Roxas BA, Li Q. Significance analysis of microarray for relative quantitation of LC/MS data in proteomics. BMC Bioinf 2008;9:187.
Grewal A, Lambert P, Stockton J. Analysis of expression data: an overview. Curr Protoc Bioinf 2007;7:7.1.
Kaba B, Pinet N, Lelandais G, Sigayret A, Berry A. Clustering gene expression data using graph separators. In Silico Biol 2007;7:433–452.
Lee YS, Tsai CN, Tsai CL, Chang SD, Hsueh DW, Liu CT, et al. Comparison of whole genome amplification methods for further quantitative analysis with microarraybased comparative genomic hybridization. Taiwan J Obstet Gynecol 2008;47:32–41.
Chen Y, Han FM, Cai M. Study on genechip technology for the evaluation of hepatotoxicity of Chinese medicines. China J Tradit Chin Med Pharm (Chin) 2003;18:336–338.
Wu ZZ, Li YH, Li M, Chen MY, Yang M. Effect of optimized memory-enhancing decoction on memory improving and its molecular mechanism. Shenzhen J Integr Tradit Chin West Med (Chin) 2007;17:278–282.
Wu ZZ, Tang CY, Lu HP. Investigation of the educational effect and its mechanism of Tiantai I on senile dementia model. China J Tradit Chin Med Pharm (Chin) 1999;14:18–22.
Wu ZZ, Tang CY, Lu HP. Effects of Buganwendan formula on learning and memory and subtype of M-cholinergic receptor in aged dementia mice. Chin J Tradit Med Sci Technol (Chin) 1998;5:223–225.
Wu ZZ, Li M, Jia XQ, Zhang YF. Influence of Tiantai No.1 Recipe on learning and memory function of spontaneous Alzheimer disease models. Chin J Clin Rehabil 2005;9:180–181.
Wu ZZ, Li M, Li YF Zhang YF. Effects of Tiantai No.1 on relative neuropeptides of spontaneous aged dementia mice. Chin J Neurosci (Chin) 2004;20:167–170.
Wu ZZ, Li YH, Li M, Zhang YP, Jia XQ, Chen MY. Quantitative study on synaptic plasticity of the spontaneous Alzheimer’s model treated with Buganyangsui Prescription by electron microscope. Chin J Tradit Med Sci Technol (Chin) 2007;14:444–446.
Wu ZZ, Li M, Li YF, Zhang YF, Jia XQ, Chen MY. Quantitative study of Tiantai No.1 on superoxidative dismutase and lipofuscin in relevant cerebral areas of spontaneous Alzheimer disease in mice. Chin J Clin Rehabil (Chin) 2005;9:178–181.
Wu ZZ, Li YH, Huang AC, Li M, Yang M, Chen MY. Natural cerebrolysin induces neuronal differentiation in bone marrow mesenchymal stem cells. Neural Regen Res 2009;4:178–185.
WU ZZ, LI YH, Huang AC, Li M, Zhang XL, Wang JG, et al. Endoplasmic reticulum stress induced by tunicamycin and antagonistic effect of Tiantai No.1 on mesenchymal stem cells. Chin J Integr Med 2010;16:41–49.
Wu ZZ, Huang AC, de Vellis J, Li YH. Effect of Tiantai No.1 on beta-amyloid-induced neurotoxicituy and NF-kappa B and cAMP responsive element-binding protein. Chin J Integr Med 2008;14:286–292.
The Ministry of Science and Technology of the People’s Republic of China. Instructional guidelines on Taking good care of experimental animals. Sep. 13, 2006. Available at: http://www.nsfc.gov.cn/nsfc/cen/pfzl/pufanew/20110801_02.pdf.
Pharmacopoeia of the People’s Republic of China. China Pharmacopoeia Committee. 2010 ed. Beijing: Chinese Medical Science and Technology Press;2010: 8, 54–55, 296–297.
Li YH, Hu L, Wu ZZ, Yu ZL, Cao MQ, Sun KH, et al. Fructus Broussonetae extract improves cognitive function and endoplasmic reticulum stress in Alzheimer’s disease models. Neural Regen Res 2011;6:2325–2331.
Holtz WA, Turetzky JM, O’Malley KI. Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death. Antioxid Redox Signal 2005;7:639–648.
Lien WH, Klezovitch O, Fernandez TE, Delrow J, Vasioukhin V. Alpha E-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. Science 2006;311:1609–1612.
Wang X, Yan ZY, Hao XF. Gene technology and modern traditional Chinese medicine. Chin Tradit Herbal Drugs (Chin) 2003;34:577–579.
Delanty N, Vaughan CJ, Sheehy N. Statins and neuroprotection. Expert Opin Investig Drugs 2001;10:1847–1853.
Cucchiara B, Kasner SE. Use of statins in CNS disorders. J Neurol Sci 2001;187:81–89.
Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlong S, Piser T. 3-hydroxy-3-methylglutaryl coenzyme A reduetase inhibitors protect cortical neurons from excitotoxieity. J Neurosci 2003:23:11104–11111.
Banfi S, Servadio A, Chung M, Capozzoli F, Duvick LA, Elde R, et al. Cloning and developmental expression analysis of the murine homolog of the spinocerebellar ataxia type I gene(Sca1). Hum Mol Genet 1996;5:33–40.
0
浏览量
95
Downloads
1
CSCD
关联资源
相关文章
相关作者
相关机构